1. Bush NA, Chang SM, Berger MS: Current and future strategies for treatment of glioma. Neurosurg Rev 2017, 40:1-14.
2. Gusyatiner O, Hegi ME: Glioma epigenetics: From subclassification to novel treatment options. Semin Cancer Biol 2018, 51:50-58.
3. Li J, Zhao J, Tan T, Liu M, Zeng Z, Zeng Y: Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review. Int J Nanomedicine 2020, 15:2563-2582.
4. Xu H, Han Y, Zhao G: Hypoxia-Responsive Lipid-Polymer Nanoparticle-Combined Imaging-Guided Surgery and Multitherapy Strategies for Glioma. ACS Appl Mater Interfaces 2020, 12:52319-52328.
5. Braganhol E, Wink MR, Lenz G, Battastini AMO: Purinergic Signaling in Glioma Progression. Adv Exp Med Biol 2020, 1202:87-108.
6. Lu L, Chen H, Wang L, Zhao L, Cheng Y, Wang A: A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma. Int J Nanomedicine 2020, 15:8875-8892.
7. Rosca L, Robert-Boire V, Delisle JF, Samson Y, Perreault S: Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas. Pediatr Blood Cancer 2018, 65:e27351.
8. Thakur A, Sidu RK: Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics. Int J Nanomedicine 2020, 15:8331-8343.
9. Zhu J, Zhang Y, Chen X, Zhang Y, Zhang K, Zheng H, Wei Y, Zheng H, Zhu J, Wu F, et al: Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB. Biochem Biophys Res Commun 2021, 534:902-907.
10. Han B, Xie W, Zhang Y, Zhou S, Yang J, Wang R, Sun Y, Wang X, Xu J, Chen D, et al: The influx/efflux mechanisms of d-peptide ligand of nAChRs across the blood-brain barrier and its therapeutic value in treating glioma. J Control Release 2020, 327:384-396.
11. Li J, Tan T, Zhao L, Liu M, You Y, Zeng Y, Chen D, Xie T, Zhang L, Fu C, Zeng Z: Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review. ACS Applied Bio Materials 2020, 3:5500-5528.
12. Smith MW, Gumbleton M: Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target 2006, 14:191-214.
13. Ferraris C, Cavalli R: Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours. Int J Nanomedicine 2020, 15:2999-3022.
14. Lu Q, Cai X, Zhang X, Li S, Song Y, Du D, Dutta P, Lin Y: Synthetic Polymer Nanoparticles Functionalized with Different Ligands for Receptor-mediated Transcytosis across Blood-Brain Barrier. ACS Appl Bio Mater 2018, 1:1687-1694.
15. Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T: Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol 2019, 181:101665.
16. Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X, Xie C, Jiang K, Li J, Zhou J, et al: Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano 2019, 13:5591-5601.
17. Fu S, Liang M, Wang Y, Cui L, Gao C, Chu X, Liu Q, Feng Y, Gong W, Yang M, et al: Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. ACS Appl Mater Interfaces 2019, 11:1841-1854.
18. Jia Y, Wang X: Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles. ACS Nano 2019, 13:386-398.
19. Datta B, Paul D, Pal U, Rakshit T: Intriguing Biomedical Applications of Synthetic and Natural Cell-Derived Vesicles: A Comparative Overview. ACS Applied Bio Materials 2021, 4:2863-2885.
20. Mo X, Zheng Z, He Y, Zhong H, Kang X, Shi M, Liu T, Jiao Z, Huang Y: Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide. J Control Release 2018, 287:12-23.
21. Jin J, Bhujwalla ZM: Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics. Front Oncol 2019, 9:1560.
22. Fang RH, Hu CM, Luk BT, Gao W, Copp JA, Tai Y, O'Connor DE, Zhang L: Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 2014, 14:2181-2188.
23. Zhao P, Wang M, Chen M, Chen Z, Peng X, Zhou F, Song J, Qu J: Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. Biomaterials 2020, 254:120142.
24. Lin GL, Wilson KM: Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med 2019, 11.
25. Zhao M, van Straten D, Broekman MLD, Préat V, Schiffelers RM: Nanocarrier-based drug combination therapy for glioblastoma. Theranostics 2020, 10:1355-1372.
26. Zhu L, Zhang C, Lü X, Song C, Wang C, Zhang M, Xie Y, Schaefer HF, 3rd: Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies. J Mol Model 2020, 26:162.
27. Duran GE, Derdau V, Weitz D, Philippe N, Blankenstein J, Atzrodt J, Sémiond D, Gianolio DA, Macé S, Sikic BI: Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein. Cancer Chemother Pharmacol 2018, 81:1095-1103.
28. Chen R, Cheng Q, Owusu-Ansah KG, Chen J, Song G, Xie H, Zhou L, Xu X, Jiang D, Zheng S: Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma. Am J Cancer Res 2018, 8:1297-1306.
29. Terada N, Kamoto T, Tsukino H, Mukai S, Akamatsu S, Inoue T, Ogawa O, Narita S, Habuchi T, Yamashita S, et al: The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients. BMC Cancer 2019, 19:156.
30. Feng HB, Wang J, Jiang HR, Mei X, Zhao YY, Chen FR, Qu Y, Sai K, Guo CC, Yang QY, et al: β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1. Stem Cells Transl Med 2017, 6:830-839.
31. Mu L, Wang T, Chen Y, Tang X, Yuan Y, Zhao Y: β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway. Int J Oncol 2016, 49:1427-1436.
32. Yang D, Xu X, Wang X, Feng W, Shen X, Zhang J, Liu H, Xie C, Wu Q, Miao X, et al: β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling. Am J Cancer Res 2021, 11:370-388.
33. Zeng YY, Zeng YJ, Zhang NN, Li CX, Xie T, Zeng ZW: The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma. Molecules 2019, 24:1697.
34. Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y: Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer. ACS Nano 2016, 10:7738-7748.
35. Jia Y, Sheng Z, Hu D, Yan F, Zhu M, Gao G, Wang P, Liu X, Wang X, Zheng H: Highly penetrative liposome nanomedicine generated by a biomimetic strategy for enhanced cancer chemotherapy. Biomater Sci 2018, 6:1546-1555.
36. Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, You Y, Wang S, Chen X, Sui X, Xie T: Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy. Int J Nanomedicine 2018, 13:6279-6296.
37. Marega R, Prasetyanto EA, Michiels C, De Cola L, Bonifazi D: Fast Targeting and Cancer Cell Uptake of Luminescent Antibody-Nanozeolite Bioconjugates. Small 2016, 12:5431-5441.
38. Zong Z, Zou J, Mao R, Ma C, Li N, Wang J, Wang X, Zhou H, Zhang L, Shi Y: M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling. Front Immunol 2019, 10:1643.
39. Bao B, Gao D, Li N, Wu M, Xing C: Near-Infrared Light Regulation of Tumor PI3K/Akt Signaling Pathway for Enhancing Cancer Cell Apoptosis through Conjugated Polymer Nanoparticles. ACS Applied Bio Materials 2020, 3:2428-2437.
40. Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, Han M: Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials 2013, 34:5628-5639.
41. Shen C, Wang X, Zheng Z, Gao C, Chen X, Zhao S, Dai Z: Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma. Int J Nanomedicine 2019, 14:101-117.
42. Yu M, Su D, Yang Y, Qin L, Hu C, Liu R, Zhou Y, Yang C, Yang X, Wang G, Gao H: D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma. ACS Appl Mater Interfaces 2019, 11:176-186.